Burning Rock Biotech
BNR
#9692
Rank
โ‚ฌ84.22 M
Marketcap
7,99ย โ‚ฌ
Share price
-3.35%
Change (1 day)
34.22%
Change (1 year)

Revenue for Burning Rock Biotech (BNR)

Revenue in 2026 (TTM): โ‚ฌ62.24 Million

According to Burning Rock Biotech's latest financial reports the company's current revenue (TTM ) is โ‚ฌ64.11 Million. In 2025 the company made a revenue of โ‚ฌ64.37 Million a decrease over the revenue in the year 2024 that were of โ‚ฌ68.85 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Burning Rock Biotech from 2019 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ62.24 M-3.31%
2025 โ‚ฌ64.37 M-6.51%
2024 โ‚ฌ68.85 M0.31%
2023 โ‚ฌ68.64 M-11.57%
2022 โ‚ฌ77.62 M11.63%
2021 โ‚ฌ69.54 M35.58%
2020 โ‚ฌ51.29 M4.24%
2019 โ‚ฌ49.2 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
LabCorp
LH
โ‚ฌ12.43 B 19,292.19%๐Ÿ‡บ๐Ÿ‡ธ USA
OpGen
OPGN
โ‚ฌ4.41 M-93.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
โ‚ฌ0.65 B 922.75%๐Ÿ‡บ๐Ÿ‡ธ USA